Title : Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.

Pub. Date : 2010 Jan 21

PMID : 19838217






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy. Oxaliplatin DNA polymerase beta Homo sapiens
2 DNA damage induced by oxaliplatin treatment of HCT116 and HT29 colon cancer cells was observed to be associated with the stabilization of Pol beta protein on chromatin. Oxaliplatin DNA polymerase beta Homo sapiens
3 In comparison with HCT116 colon cancer cells, isogenic oxaliplatin-resistant (HCT-OR) cells were found to have higher constitutive levels of Pol beta protein, faster in vitro repair of a DNA substrate containing a single nucleotide gap and faster repair of 1,2-GG oxaliplatin adduct levels in cells. Oxaliplatin DNA polymerase beta Homo sapiens
4 In HCT-OR cells, small interfering RNA knockdown of Pol beta delayed the repair of oxaliplatin-induced DNA damage. Oxaliplatin DNA polymerase beta Homo sapiens
5 In a different model system, Pol beta-deficient fibroblasts were less able to repair 1,2-GG oxaliplatin adducts and were hypersensitive to oxaliplatin treatment compared with isogenic Pol beta-expressing cells. Oxaliplatin DNA polymerase beta Homo sapiens
6 In a different model system, Pol beta-deficient fibroblasts were less able to repair 1,2-GG oxaliplatin adducts and were hypersensitive to oxaliplatin treatment compared with isogenic Pol beta-expressing cells. Oxaliplatin DNA polymerase beta Homo sapiens
7 These data provide the first link between oxaliplatin sensitivity and DNA repair involving Pol beta. Oxaliplatin DNA polymerase beta Homo sapiens
8 They demonstrate that Pol beta modulates the sensitivity of cells to oxaliplatin treatment. Oxaliplatin DNA polymerase beta Homo sapiens